摘要
目的 观察促血管生成素 (angiopoietin)在肝细胞癌组织中的表达 ,探讨其临床意义。方法 采用原位分子杂交和免疫组织化学染色方法检测两种促血管生成素Angiopoietin 1(Ang 1)、Angiopoietin 2 (Ang 2 )以及血管平滑肌激动蛋白 (α smoothmuscleactin ,α SMA)在正常肝脏组织和肝细胞癌组织中的表达。结果 Ang 1mRNA在正常肝脏和肝癌组织中都有表达 ,肝癌组织和癌旁组织 (5 6± 6 /HP)以及正常肝脏 (6 7± 11/HP)之间差异没有显著意义 (t=3 2 14 ,P =0 12 6 )。Ang 2mRNA在正常肝脏不表达 ,肝癌组织中阳性表达 (阳性细胞数为 32± 8/HP)。Ang 2集中于癌灶边缘、血管周围。肝癌组织中微血管密度 (15± 2 /HP)和新生血管的数量 (9± 3/HP)明显高于正常肝脏(分别为 5± 1/HP和阴性 ) ,Ang 2的表达随肝癌组织的病理学分级、有无转移以及新生血管数和微血管密度而增加 (t=2 714 ,P =0 0 31)。结论 促血管生成素在肝癌的新生血管形成和转移过程中可能起到一定作用。Ang 2可能参与了肝癌的新生血管形成。
ObjectiveTo study the expression of angiopoietin in hepatocellular carcinoma tissue, and its relation with tumor angiogenesis and clinical significance. Methods Using immunohistochemistry and in situ hybridization, we observed the expression of angiopoietin 1(Ang 1) and angiopoietin 2(Ang 2) mRNA in 21 HCC patients and 5 normal liver tissues. The correlation between angiopoietin expression and several pathological markers was analyzed with computer statistical tools. Results Ang 1 equally expressed in tumor tissue, the adjacent noncarcinomatous tissue and normal liver. Ang 2 was highly expressed in tumor tissue, especially in tumor margin. The difference was significant between the group with metastasis and that without ( P <0 05). Conclusions Angiopoietin may play a role in HCC angiogenesis and tumor metastasis. Ang 2 plays a potential role in the angiogenesis.
出处
《中华普通外科杂志》
CSCD
北大核心
2003年第7期430-432,共3页
Chinese Journal of General Surgery
基金
广东省医学科学基金项目 (A2 0 0 2 0 42 )
